Chicago Tribune - October 14, 2001
Ronald Kotulak and Jon Van
Reporting in the Journal Neurology, French researchers described six people afflicted with ALS symptoms among some 1,700 AIDS patients being studied. Also in the journal was a report of a woman who first developed ALS-like symptoms who then was found to be positive for HIV, the virus that causes AIDS.
In all seven cases, treatment for HIV resulted in either eliminating the ALS symptoms or at least stabilizing them. Because ALS is a progressive disease with no treatment known to stop or reverse it, this was deemed significant.
Researchers long have debated whether ALS is caused by a virus, and the new findings argue for that possibility.
"This is exciting news because if this form of ALS caused by HIV is treatable, then other forms of ALS may be treatable as well," said Dr. Burk Jubelt, a neurologist at SUNY Upstate Medical University in Syracuse, N.Y., who authored an editorial that accompanied the two journal articles.
Doctors wrong on checkout time
If you're at death's door, don't count on your doctor to give you the exact time of departure.
A University of Chicago study of 326 patients dying from cancer found that even when they requested survival times, doctors would give the patients frank estimates only 37 percent of the time and would provide no estimate or either overly optimistic or pessimistic estimates 63 percent of the time.
Part of the problem is that patients want to hear good news, which makes physicians less willing to be frank, said Dr. Nicholas A. Christakis.
Spare the eye-care radiation
Applying radiation to the area around the eyeball of someone with Graves' disease is a widely used treatment that apparently is useless, a Mayo Clinic study published in the journal Ophthalmology concludes.
The study, which included only patients with mild to moderately severe cases of the eye disease caused by an abnormal thyroid, compared eyes in the same patients, treating one but not the other. It found treatment made no discernable difference.
"The effectiveness of this treatment, which has been widely used for 80 years, has never been convincingly established," said Dr. Colum Gorman, a Mayo Clinic endocrinologist. "Because this treatment is still in wide use, is expensive and not without risk, it is our belief that it should not be used for patients with mild or moderately severe ophthalmopathy."
Graves' disease often remits naturally, Gorman said, and a patient's eye condition will improve on its own, which is probably why doctors using radiation therapy thought it was working.
011014
CT011001
Copyright © 2001 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611 http://www.chicagotribune.com
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .